Patents by Inventor Franklin Pass

Franklin Pass has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250180565
    Abstract: Provided herein are anti-HER2 monoclonal antibodies or binding fragments thereof and uses thereof.
    Type: Application
    Filed: February 9, 2023
    Publication date: June 5, 2025
    Inventors: Franklin Pass, Steven Stoesz, Justin Lengfeld
  • Publication number: 20240210403
    Abstract: Provided herein is a point-of-care multiple diagnostic assay with multiple test lines allowing the rapid and simultaneous detection of multiple analytes present in samples, including, for example, HER2 positive hyperproliferative disorders such as a neoplastic disorders.
    Type: Application
    Filed: April 15, 2022
    Publication date: June 27, 2024
    Inventors: Franklin Pass, Steven Stoesz, Justin Lengfeld
  • Publication number: 20060106362
    Abstract: The invention relates to a method for minimizing mean blood glucose levels in an insulin dependent patient by administering insulin to the patient in a sufficiently fast manner to provide a difference of 50% or less between high and low blood glucose levels. Advantageously, the insulin is administered to the patient by jet injection and the high and low blood glucose levels differ by an amount that is less than that which would be obtained after injection of insulin by a conventional needle syringe. The invention also relates to a method for reducing mean blood glucose levels in an insulin dependent patient that is receiving insulin through a conventional syringe and needle arrangement. This method provides for administration of the insulin to the patient by jet injection rather than by the syringe by substituting a jet injector for the syringe.
    Type: Application
    Filed: April 29, 2005
    Publication date: May 18, 2006
    Inventors: Franklin Pass, Mario Velussi
  • Publication number: 20030040697
    Abstract: The invention relates to a method for minimizing mean blood glucose levels in an insulin dependent patient by administering insulin to the patient in a sufficiently fast manner to provide a difference of 50% or less between high and low blood glucose levels. Advantageously, the insulin is administered to the patient by jet injection and the high and low blood glucose levels differ by an amount that is less than that which would be obtained after injection of insulin by a conventional needle syringe. The invention also relates to a method for reducing mean blood glucose levels in an insulin dependent patient that is receiving insulin through a conventional syringe and needle arrangement. This method provides for administration of the insulin to the patient by jet injection rather than by the syringe by substituting a jet injector for the syringe.
    Type: Application
    Filed: August 16, 2002
    Publication date: February 27, 2003
    Applicant: ANTARES PHARMA, INC.
    Inventors: Franklin Pass, Mario Velussi